Program Overview

Activity Description Objectives

Target Audience Method of Participation

Term of Approval Acknowledgement of Support

Activity Description

Major depressive disorder (MDD) is a serious disease that affects more than 16 % of US adults. At any given time, 5%-9% of women and 2%-3% of men are likely to be clinically depressed. The management of such disorders depends upon first-generation antidepressants and more recently developed second-generation antidepressants. The second-generation antidepressants exhibit a more favorable adverse event profile yet similar efficacy when compared to the first-generation drugs thus play a more prominent role in managing patients with MDD.

The Agency for Healthcare Research and Quality (AHRQ) commissioned a comparative effectiveness review of published studies in 2011 updating an original report from 2007. The report focused on second-generation antidepressants and summarized the available evidence on the comparative efficacy, effectiveness, and harms of 13 second-generation antidepressants in managing patients with MDD, dysthymia, and subsyndromal depression. It also assessed the comparative efficacy and effectiveness for sustaining remission and for treating associated symptoms such as anxiety, insomnia, or neurovegetative symptoms. Based on the evidence obtained from the AHRQ systematic reviews, this interactive video challenges health care professionals to think critically about optimal patient-centered therapies for managing MDD.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

• Compare the effectiveness and efficacy of antidepressants in treating depressive symptoms in adults
• Assess the benefits and harms of antidepressants among certain adult patient subgroups
• Apply the findings of the systematic review to improve outcomes for adult patients through patient-centered care

Target Audience

This CME activity is designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, nurses, case managers and health education specialists.

Method of Participation

To receive a certificate for this activity, you should:

• Complete the learner assessment pretest
• View the entire activity online
• Complete an online evaluation & post-test
• Print your certificate online

The estimated time to complete this activity, including review of the materials, is 1.0 hour.

Term of Approval

June 30, 2012 through June 29, 2014. Original release date: June 30, 2012

Acknowledgement of Support

There is no fee for this CME/CE activity. This activity is sponsored by PRIME Education, Inc (PRIME^®) and funded under contract HHSA290201000006G from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).

Faculty Biographies and Disclosures

Begin Activity

Accreditation/Credit Designation

Physician Credit Designation Statement

PRIME Education, Inc. (PRIME^®) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

PRIME^® designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

Psychologist Accreditation Statement

PRIME Education, Inc. (PRIME^®) is approved by the American Psychological Association to sponsor continuing education for psychologists. PRIME^® maintains responsibility for this program and its content.

Nurse Practitioner Accreditation Statement

PRIME Education, Inc (PRIME^®) is approved as a provider of Nurse Practitioner Continuing Education by the American Association of Nurse Practitioners. Provider number: 060815. This program is accredited for 1.0 contact hour. Program ID# CER34.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Pharmacist Accreditation Statement

This curriculum has been approved for 1.0 contact hour (0.1 CEUs) by PRIME^®. PRIME^® is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is 0255-0000-12-031-H01-P. This learning activity is Knowledge-Based.

Nurse Accreditation Statement

PRIME Education, Inc. (PRIME^®) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

PRIME^® designates this activity for 1.0 contact hour.

Case Manager Accreditation Statement

The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers.

Certified Health Education Specialist Accreditation Statement

Sponsored by PRIME Education, Inc. (PRIME^®), a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.

This program is designated for Certified Health Education Specialists (CHES) to receive up to 1.0 Category I contact hours in health education.

CHES Provider Number: MEP3774

Begin Activity

Faculty Disclosures

Disclosure Policy

PRIME Education Inc (PRIME^®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

PRIME^® willidentify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.

Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME^®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.

Content validation methods are consistently utilized by PRIME^® to ensure that all program content is evidence-based, fair-balanced, and developed with scientific rigor and integrity. All clinical recommendations are based on evidence accepted within the medical profession. All scientific research referred to, reported or used to support a clinical recommendation conforms to accepted standards of experimental design, data collection and analysis. In addition to review of content by course directors and expert faculty, content is also validated through independent peer reviewers selected for their expertise in the content area, as well as their experience in the intended audience. All peer reviewers, planners, course directors, faculty and relevant staff utilized by PRIME^® complete disclosures which are related to their role in the educational activity.

Accessibility

PRIME^®is committed to providing access to our CME programs for individuals with disabilities as identified in Section 508 of the Rehabilitation Act for all web-based programs. This website is 508 compliant.

Begin Activity

Post-Test & Evaluation

You must access the activity before receiving credit!

Clinician & Consumer Summaries on Adult Depression

Download these free summaries for your reference and/or patient handouts. You may also order bulk copies free of charge from the AHRQ Publication Clearinghouse below.